about
Immunotherapy for metastatic renal cell carcinomaEffect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTEAxitinib for the management of metastatic renal cell carcinomaManagement of renal cell carcinoma with solitary metastasisGene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancersContemporary Treatment of Metastatic Renal Cell CarcinomaEffects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumorsDifferentiating mTOR inhibitors in renal cell carcinomaThe RPTEC/TERT1 Cell Line as an Improved Tool for In Vitro Nephrotoxicity AssessmentsImaging review of skeletal tumors of the pelvis malignant tumors and tumor mimicsFighting against kidney diseases with small interfering RNA: opportunities and challengesTherapy management of cardiovascular adverse events in the context of targeted therapy for metastatic renal cell carcinomaMesoscale nanoparticles selectively target the renal proximal tubule epitheliumDiagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocolSunitinib in the treatment of metastatic renal cell carcinomaLactic acidosis triggers starvation response with paradoxical induction of TXNIP through MondoADifferential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcomeNuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell AdenocarcinomaCadmium alters the formation of benzo[a]pyrene DNA adducts in the RPTEC/TERT1 human renal proximal tubule epithelial cell lineImmunotherapy for metastatic renal cell carcinoma.CXC motif chemokine receptor 4 gene polymorphism and cancer risk.Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concernIdentification of Protein Markers Specific for Papillary Renal Cell Carcinoma Using Imaging Mass SpectrometryVascular endothelial growth factor as an anti-angiogenic target for cancer therapyRole of open nephron sparing surgery in the era of minimal invasive surgery.Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model.Metastases from renal cell carcinoma presenting as gastrointestinal bleeding: two case reports and a review of the literatureIncreased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasisPhase I trial of sunitinib malate plus interferon-alpha for patients with metastatic renal cell carcinoma.Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles.Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma.Efficacy of sorafenib on metastatic renal cell carcinoma in Asian patients: results from a multicenter studyIncreased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma.Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer.Nasal metastases from renal cell carcinoma are associated with Memorial Sloan-Kettering Cancer Center poor-prognosis classification.Metastatic Renal Cell Carcinoma to Jejunum: An Unusual Case Presentation.Molecular targeted therapy in advanced renal cell carcinoma: A review of its recent past and a glimpse into the near futureRecent progress in cytokine therapy for renal cell cancer: a case for the European Organization for Research and Treatment of Cancer adjuvant cytokine trial in patients with poor-risk renal cell cancer after maximum debulking surgery.A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy.Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib
P2860
Q24186688-03450A69-96CD-4BD5-9C70-E1AF578F1627Q24202706-592885A2-3280-4FEE-901B-B2D9B23E1F08Q24613720-DBD04FC3-03B3-49A8-978F-3C5772FC2E79Q24813123-FCE65DD4-CB1B-46F9-B4DD-459CCB6A6652Q25255387-B1BBED15-D9C8-467D-AF78-1FDE137CBE3FQ26740594-3E2C8AD0-13C5-47EE-9274-203D450FC421Q26799046-E05C5C0B-BF90-4F51-B2F8-C0835CD4BCF8Q26860172-BC2EE5B7-85F4-4F9F-8DC3-7333FCDA0D11Q26862114-B8064206-99BB-4F5B-A659-DECA4EB181EDQ27003089-8E2C84B0-9D4E-4D53-8F95-C6FE89EAF6A5Q27010574-85A23D99-150C-4817-8A14-B45EEF0396F4Q27013665-89BFE63A-D2B2-4517-AAA4-AECA21A36793Q27335127-0345862C-83BB-4853-BE0A-8D22430B2F2FQ28071747-90B5584B-CDE1-4C9F-B16D-06BC5B9717DCQ28072057-260A88EE-33B3-42F4-BD4A-2D59687B9A15Q28475481-B9BDB902-070F-4966-B4C6-DBC79F10C896Q28486028-7194A165-9736-4DCD-8340-47E0C6A80705Q28547741-4231A89F-A476-4419-BB31-F6926595FE0EQ28654305-E90C1F9B-004B-4168-B1CE-4355247F4BA4Q30234458-D9567D8B-A152-4590-B11A-D3395234A0F1Q30240169-16B0473E-9FBD-4460-9AA5-3D21C3F47B2FQ30379686-CF8C59F3-7EC4-4A7A-B985-C27D59206492Q30406355-9AEFFC69-940E-490D-8F7C-DE216EDA65EBQ30455612-5D7B3331-35BF-4454-9F66-8743FB80B074Q30940211-1C414054-D9C6-428B-86DE-239B2DFD351FQ33268699-41FC765F-1D01-4949-A55C-35E24C65D374Q33271196-4B926695-C830-4012-ABC8-B8466144D108Q33294127-37D1EC1D-4B6A-4229-8DFF-F32756317715Q33383270-373FD825-4C6D-4DD3-BA73-B01480501422Q33396613-B670CDBB-97C4-4F29-B9DD-169D23CFFE71Q33435816-2A80B425-740C-4F9F-91D2-F653491DC87AQ33485003-B0328AD6-E549-408A-96BB-6535F51422B2Q33490826-7D5A4A1E-DB72-4155-BCA1-B8520A840127Q33491820-086883AD-979D-4380-9FC6-2E6387EEA89CQ33579457-FAF9C749-F74C-4832-8F47-89C3E93F486AQ33580175-9BDF31CE-EC60-4379-BF41-BBBA9D4B20C6Q33599713-A70F0CCB-AEF4-402E-9BA7-44E92342EA63Q33610888-E9B2BBB7-969F-4247-ACD3-83514597E427Q33642615-F90E83DE-F132-4FFE-A218-82995479B996Q33665833-9545A62F-0908-4C5C-969C-521BE6DE9FDE
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Renal-cell carcinoma.
@ast
Renal-cell carcinoma.
@en
Renal-cell carcinoma.
@nl
type
label
Renal-cell carcinoma.
@ast
Renal-cell carcinoma.
@en
Renal-cell carcinoma.
@nl
prefLabel
Renal-cell carcinoma.
@ast
Renal-cell carcinoma.
@en
Renal-cell carcinoma.
@nl
P2093
P1476
Renal-cell carcinoma.
@en
P2093
P304
P356
10.1056/NEJM199609193351207
P407
P577
1996-09-01T00:00:00Z